2026 Global: Magnetic Resonance Imaging (Mri) Devices Market-Competitive Review (2032) report
Description
The 2026 Global: Magnetic Resonance Imaging (Mri) Devices Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
The Magnetic Resonance Imaging (MRI) devices market is dominated by ten major companies, led by Siemens Healthineers with a commanding 40% market share and $3.20 billion in 2024 revenue, followed closely by GE HealthCare at 36% share and $2.85 billion. These leaders innovate in high-field systems like 3T and 7T scanners, AI-enhanced imaging, and portable devices, driving a market projected to reach $14.18 billion by 2035 at a 6.52% CAGR. Siemens Healthineers, headquartered in Erlangen, Germany, excels with products like MAGNETOM Vida and Terra 7T, leveraging AI for superior diagnostics and operating in over 70 countries. GE HealthCare, based in Chicago, United States, offers versatile 1.5T and 3T systems such as OPTIMA MR360, with a global footprint in 140+ countries and strong R&D in Bangalore, India. Koninklijke Philips N.V., located in Amsterdam, Netherlands, holds 23% share ($1.90 billion revenue) with Ingenia Ambition and BlueSeal series, maintaining 93 production sites worldwide.
Canon Medical Systems, headquartered in Otawara, Japan, commands 12% market share ($0.95 billion) through high-field scanners like Vantage Galan 3T, emphasizing patient comfort and expanding in Latin America. Fujifilm Holdings (incorporating Hitachi), also in Tokyo, Japan, secures 10% share ($0.80 billion) with open MRI solutions, recently unveiling Echelon Synergy and leading in Middle East & Africa. United Imaging Healthcare, based in Shanghai, China, grows rapidly at 7% share ($0.60 billion, 18% CAGR), offering premium 7T systems like uMR Jasper and dominating Asia-Pacific. Esaote S.p.A., headquartered in Genoa, Italy, focuses on dedicated MSK imaging with 3% share ($0.25 billion), serving niche orthopedic needs across Europe.
Neusoft Medical Systems, located in Shenyang, China, provides value 1.5T scanners at 3% share ($0.22 billion), targeting cost-sensitive markets. Synaptive Medical, based in Toronto, Canada, specializes in intra-operative MRI with 2% share ($0.15 billion), aiding neurosurgery precision. Hyperfine, headquartered in Guilford, United States, disrupts with portable 0.064T devices at 1% share ($0.05 billion), enabling bedside imaging and point-of-care applications. These firms collectively control over 90% of the market, fueled by R&D investments in AI, reduced helium use, and emerging market expansion, though competition intensifies from players like Bruker and Fonar.
The Magnetic Resonance Imaging (MRI) devices market is dominated by ten major companies, led by Siemens Healthineers with a commanding 40% market share and $3.20 billion in 2024 revenue, followed closely by GE HealthCare at 36% share and $2.85 billion. These leaders innovate in high-field systems like 3T and 7T scanners, AI-enhanced imaging, and portable devices, driving a market projected to reach $14.18 billion by 2035 at a 6.52% CAGR. Siemens Healthineers, headquartered in Erlangen, Germany, excels with products like MAGNETOM Vida and Terra 7T, leveraging AI for superior diagnostics and operating in over 70 countries. GE HealthCare, based in Chicago, United States, offers versatile 1.5T and 3T systems such as OPTIMA MR360, with a global footprint in 140+ countries and strong R&D in Bangalore, India. Koninklijke Philips N.V., located in Amsterdam, Netherlands, holds 23% share ($1.90 billion revenue) with Ingenia Ambition and BlueSeal series, maintaining 93 production sites worldwide.
Canon Medical Systems, headquartered in Otawara, Japan, commands 12% market share ($0.95 billion) through high-field scanners like Vantage Galan 3T, emphasizing patient comfort and expanding in Latin America. Fujifilm Holdings (incorporating Hitachi), also in Tokyo, Japan, secures 10% share ($0.80 billion) with open MRI solutions, recently unveiling Echelon Synergy and leading in Middle East & Africa. United Imaging Healthcare, based in Shanghai, China, grows rapidly at 7% share ($0.60 billion, 18% CAGR), offering premium 7T systems like uMR Jasper and dominating Asia-Pacific. Esaote S.p.A., headquartered in Genoa, Italy, focuses on dedicated MSK imaging with 3% share ($0.25 billion), serving niche orthopedic needs across Europe.
Neusoft Medical Systems, located in Shenyang, China, provides value 1.5T scanners at 3% share ($0.22 billion), targeting cost-sensitive markets. Synaptive Medical, based in Toronto, Canada, specializes in intra-operative MRI with 2% share ($0.15 billion), aiding neurosurgery precision. Hyperfine, headquartered in Guilford, United States, disrupts with portable 0.064T devices at 1% share ($0.05 billion), enabling bedside imaging and point-of-care applications. These firms collectively control over 90% of the market, fueled by R&D investments in AI, reduced helium use, and emerging market expansion, though competition intensifies from players like Bruker and Fonar.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
